Cutaneous T-Cell Lymphoma

Weenig, Roger H.; Pittelkow, Mark R.; Niewold, Timothy B.; Swaroop, Vege Santhi
August 2003
Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p1054
Academic Journal
Comments on the findings of a report by Niewold and Swaroop in the 2003 issue of 'Mayo Clinic Proceedings' and the issues they raised concerning the diagnosis of cutaneously lymphomas. Immunophenotype of the lymphoma; Most indolent and most common form of primary cutaneous T-cell lymphoma; Cause of anemia; Histological findings.


Related Articles

  • In reply. Niewold, Timothy B.; Swaroop, Vege Santhi // Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p1054 

    Replies to issues raised by Weenig and Pittelkov concerning findings of a 'Mayo Clinic Proceedings' report on the diagnosis of cutaneous T-cell lymphoma. Cross-reactivity of some polyclonal CD3 immuno-phenotyping assays with natural killer cells; Primary cutaneous T-cell lymphoma; Appearance...

  • MYC Immunohistochemistry Assessment in High-Grade Lymphomas: Hit or Miss? Bigras, Gilbert // American Journal of Clinical Pathology;Feb2016, Vol. 145 Issue 2, p155 

    The author presents insights on the use of MYC immunohistochemistry assessment in diagnosing high-grade lymphomas. He states that 10 to 15% of diffuse large cell B-Cell lymphomas (DLBCL) are MYC driven. He cites a study which describes an IHC method for identifying DLBCL with increased MYC...

  • Lymphoproliferative Neoplasms of the Lung. William, Josette; Variakojis, Daina; Yeldandi, Anjana; Raparia, Kirtee // Archives of Pathology & Laboratory Medicine;Mar2013, Vol. 137 Issue 3, p382 

    Context.-Diagnosis and classification of lymphomas are based on the morphologic, immunologic, and genetic features that the lesional cells share with their normal B and T lymphocyte counterparts. Primary pulmonary lymphomas account for 0.3% of primary lung neoplasms and less than 0.5% of all...

  • Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients. Meignan, Michel; Sasanelli, Myriam; Casasnovas, René; Luminari, Stefano; Fioroni, Federica; Coriani, Chiara; Masset, Helene; Itti, Emmanuel; Gobbi, Paolo; Merli, Francesco; Versari, Annibale // European Journal of Nuclear Medicine & Molecular Imaging;Jun2014, Vol. 41 Issue 6, p1113 

    Purpose: The presence of a bulky tumour at staging on CT is an independent prognostic factor in malignant lymphomas. However, its prognostic value is limited in diffuse disease. Total metabolic tumour volume (TMTV) determined on F-FDG PET/CT could give a better evaluation of the total tumour...

  • High incidence of false-positive PET scans in patients with aggressive non-Hodgkins lymphoma treated with rituximab-containing regimens. H. S. Han; M. P. Escalón; B. Hsiao; A. Serafini; I. S. Lossos // Annals of Oncology;Feb2009, Vol. 20 Issue 2, p309 

    Background: Positron emission tomography (PET) is a powerful predictor of relapse and survival in non-Hodgkin’s lymphomas (NHLs) based on studies carried out in the prerituximab era. Little is known about the predictive power of PET in rituximab-treated patients. Patients and...

  • Asymptomatický makroadenom hypofýzy komprimující optické chiasma -- „incidentalom" -- identifikovaný pÅ™i diagnostickém stážování nemocného s primá... T., Szotkowski; Z., Fryšák; P., Koranda; E., Čecháková // Transfusiology & Haematology Today / Transfuze a Hematologie Dne;Mar2012, Vol. 18 Issue 1, p39 

    A case of 63-year-old man with an asymptomatic pituitary expansion found within a staging of a newly diagnosed lymphoma is presented. Histological examination of the right orbit tumour affecting adjoined parts of skeleton and paranasal sinuses determined the diagnosis of diffuse large B-cell...

  • Early death in patients diagnosed with non-Hodgkin's lymphoma. Bairey, Osnat; Bar-Natan, Michal; Shpilberg, Ofer // Annals of Hematology;Mar2013, Vol. 92 Issue 3, p345 

    This study sought to identify risk factors for early death in non-Hodgkin's lymphoma (NHL). The databases of a tertiary medical center were reviewed for adult patients diagnosed with NHL since 1985 who died within 4 months of diagnosis. Comprehensive background, disease-related data, and...

  • Manifestation of lymphoma expansion following lymphatic drainage on F-FDG PET/CT. Eshuis, Silvia; Dierckx, Rudi; Snick, Paul; Slart, Riemer; Glaudemans, Andor // European Journal of Nuclear Medicine & Molecular Imaging;Nov2011, Vol. 38 Issue 11, p2100 

    The article offers information on the case of a 70-year-old female patient diagnosed with diffuse large B-cell lymphomas (DLBCL). It mentions that fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging was performed for restaging of lymphoma disease in the patient in which it showed...

  • Gamapatias Monoclonais de Significado Indeterminado: Critérios de Diagnóstico e Acompanhamento Clínico. PARREIRA, Joana; LÚCIO, Paulo; JOÃO, Cristina; MACEDO, Ana; SARMENTO, Ana Bela; GERALDES, Catarina; GONÇALVES, Cristina; ESTEVES, Graça // Acta Medica Portuguesa;set/out2014, Vol. 27 Issue 5, p661 

    The Portuguese group of multiple myeloma of the Portuguese Society of Hematology proposes a national protocol for diagnosis and clinical follow-up of monoclonal gammopathies. The proposed protocol aims to standardize clinical management of monoclonal gammopathies. Furthermore, it would also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics